{
  "doc_id": "e0362794b64867f7e3e1253c308162c05d7b3216e46255f3b0805b4bc205ed3f",
  "chunk_entities": [
    {
      "chunk_id": "52957fcbf8e52d0961e8a5a4706af952",
      "entities": [
        {
          "entity_type": "Disease",
          "entity_name": "COPD",
          "context": "in COPD"
        },
        {
          "entity_type": "Effect",
          "entity_name": "prevent the accelerated decline in lung function",
          "context": "does not prevent the accelerated decline in lung function"
        }
      ]
    },
    {
      "chunk_id": "7fe2c68df9e12ccd48444f28758d7bc0",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "prostaglandins",
          "context": "including prostaglandins, leukotrienes, chemokines, cytokines, proteases and growth factors"
        },
        {
          "entity_type": "Compound",
          "entity_name": "leukotrienes",
          "context": "including prostaglandins, leukotrienes, chemokines, cytokines, proteases and growth factors"
        },
        {
          "entity_type": "Compound",
          "entity_name": "chemokines",
          "context": "including prostaglandins, leukotrienes, chemokines, cytokines, proteases and growth factors"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cytokines",
          "context": "including prostaglandins, leukotrienes, chemokines, cytokines, proteases and growth factors"
        },
        {
          "entity_type": "Compound",
          "entity_name": "proteases",
          "context": "including prostaglandins, leukotrienes, chemokines, cytokines, proteases and growth factors"
        },
        {
          "entity_type": "Compound",
          "entity_name": "growth factors",
          "context": "including prostaglandins, leukotrienes, chemokines, cytokines, proteases and growth factors"
        },
        {
          "entity_type": "Disease",
          "entity_name": "asthma",
          "context": "pathogenesis of asthma and COPD"
        },
        {
          "entity_type": "Disease",
          "entity_name": "COPD",
          "context": "pathogenesis of asthma and COPD"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4",
          "context": "PDE4 is expressed in a number of cell types"
        },
        {
          "entity_type": "Disease",
          "entity_name": "respiratory diseases",
          "context": "treatment of respiratory diseases such as asthma and COPD"
        },
        {
          "entity_type": "Disease",
          "entity_name": "asthma",
          "context": "treatment of respiratory diseases such as asthma and COPD"
        },
        {
          "entity_type": "Disease",
          "entity_name": "COPD",
          "context": "treatment of respiratory diseases such as asthma and COPD"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4",
          "context": "targeting PDE4 could potentially suppress the function"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE enzymes",
          "context": "other PDE enzymes"
        }
      ]
    },
    {
      "chunk_id": "8895499d4eef65849c201aa8f681dec3",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "cluster of differentiation",
          "context": "CD, cluster of differentiation"
        },
        {
          "entity_type": "Disease",
          "entity_name": "chronic obstructive pulmonary disease",
          "context": "COPD, chronic obstructive pulmonary disease"
        },
        {
          "entity_type": "Compound",
          "entity_name": "interleukin",
          "context": "IL, interleukin"
        },
        {
          "entity_type": "Compound",
          "entity_name": "tumour necrosis factor",
          "context": "TNF, tumour necrosis factor"
        }
      ]
    },
    {
      "chunk_id": "47cf5147f47812ec616267c02786b641",
      "entities": [
        {
          "entity_type": "Disease",
          "entity_name": "COPD",
          "context": "preclinical in vivo models of COPD"
        },
        {
          "entity_type": "Compound",
          "entity_name": "endotoxin",
          "context": "bacterial wall component, endotoxin"
        },
        {
          "entity_type": "Effect",
          "entity_name": "recruitment of neutrophils",
          "context": "recruitment of neutrophils to the airways"
        },
        {
          "entity_type": "Effect",
          "entity_name": "inhibited",
          "context": "was inhibited by around 50%"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "around 50%",
          "context": "inhibited by around 50%"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4B",
          "context": "in PDE4B and PDE4D-deficient mice"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D",
          "context": "in PDE4B and PDE4D-deficient mice"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "treated with rolipram"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 isoforms",
          "context": "roles of PDE4 isoforms"
        },
        {
          "entity_type": "Effect",
          "entity_name": "regulating neutrophil recruitment",
          "context": "regulating neutrophil recruitment to the airways"
        },
        {
          "entity_type": "Effect",
          "entity_name": "neutrophil recruitment",
          "context": "smoking induced neutrophil recruitment to the airways"
        },
        {
          "entity_type": "Effect",
          "entity_name": "release of chemokines",
          "context": "release of chemokines"
        },
        {
          "entity_type": "Compound",
          "entity_name": "chemokines",
          "context": "release of chemokines"
        },
        {
          "entity_type": "Disease",
          "entity_name": "emphysematous changes",
          "context": "emphysematous changes to the lung"
        },
        {
          "entity_type": "Effect",
          "entity_name": "attenuated",
          "context": "were attenuated by PDE4 inhibitors"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 inhibitors",
          "context": "attenuated by PDE4 inhibitors"
        }
      ]
    },
    {
      "chunk_id": "925c3b8b71981e012672269ef98fdc14",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "PDE4",
          "context": "inhibiting PDE4"
        },
        {
          "entity_type": "Effect",
          "entity_name": "inhibiting",
          "context": "utility of inhibiting PDE4"
        },
        {
          "entity_type": "Disease",
          "entity_name": "disease",
          "context": "implicated in this disease"
        }
      ]
    },
    {
      "chunk_id": "8b57960a0d4fe5165486b6556180de4a",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 inhibitors",
          "context": "utility of PDE4 inhibitors in the treatment of COPD"
        },
        {
          "entity_type": "Disease",
          "entity_name": "COPD",
          "context": "in the treatment of COPD (Rabe et al., 2005)"
        },
        {
          "entity_type": "Disease",
          "entity_name": "COPD",
          "context": "group of COPD patients."
        },
        {
          "entity_type": "Effect",
          "entity_name": "relaxation of airway smooth muscle",
          "context": "due to relaxation of airway smooth muscle because this drug class"
        },
        {
          "entity_type": "Effect",
          "entity_name": "bronchodilator activity",
          "context": "this drug class has weak bronchodilator activity."
        },
        {
          "entity_type": "Effect",
          "entity_name": "anti-inflammatory action",
          "context": "due to an anti-inflammatory action of the drugs"
        },
        {
          "entity_type": "Effect",
          "entity_name": "inflammation",
          "context": "biomarker of inflammation was measured in these studies."
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 inhibitors",
          "context": "whether PDE4 inhibitors are anti-inflammatory in COPD."
        },
        {
          "entity_type": "Effect",
          "entity_name": "anti-inflammatory",
          "context": "PDE4 inhibitors are anti-inflammatory in COPD."
        },
        {
          "entity_type": "Disease",
          "entity_name": "COPD",
          "context": "are anti-inflammatory in COPD."
        },
        {
          "entity_type": "Compound",
          "entity_name": "roflumilast",
          "context": "Both roflumilast (Grootendorst et al., 2007) and cilomilast"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cilomilast",
          "context": "and cilomilast (Gamble et al., 2003) reduced the number of inflammatory cells"
        },
        {
          "entity_type": "Effect",
          "entity_name": "inflammatory cells",
          "context": "reduced the number of inflammatory cells such as neutrophils and lymphocytes"
        },
        {
          "entity_type": "Compound",
          "entity_name": "neutrophils",
          "context": "inflammatory cells such as neutrophils and lymphocytes recruited to the airways"
        },
        {
          "entity_type": "Compound",
          "entity_name": "lymphocytes",
          "context": "neutrophils and lymphocytes recruited to the airways and the levels"
        },
        {
          "entity_type": "Compound",
          "entity_name": "interleukin-8",
          "context": "namely interleukin-8 and neutrophil elastase."
        },
        {
          "entity_type": "Compound",
          "entity_name": "neutrophil elastase",
          "context": "interleukin-8 and neutrophil elastase."
        },
        {
          "entity_type": "Disease",
          "entity_name": "this disease",
          "context": "biochemical markers of this disease, namely interleukin-8"
        },
        {
          "entity_type": "Effect",
          "entity_name": "beneficial action",
          "context": "underlie their beneficial action in the phase III clinical trials."
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4",
          "context": "inhibition of PDE4 was not achievable because of dose-limiting side effects"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE3",
          "context": "other PDE isoforms (for example, PDE3, 7, see Table 1)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE7",
          "context": "PDE3, 7, see Table 1) in these same inflammatory processes"
        },
        {
          "entity_type": "Effect",
          "entity_name": "inflammatory processes",
          "context": "in these same inflammatory processes may also require targeting"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anti-inflammatory action",
          "context": "for a full anti-inflammatory action to be revealed in this disease."
        },
        {
          "entity_type": "Disease",
          "entity_name": "this disease",
          "context": "action to be revealed in this disease."
        }
      ]
    },
    {
      "chunk_id": "166efba6fb3648514747dfc5171c65ee",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "roflumilast",
          "context": "reported with roflumilast included diarrhoea"
        },
        {
          "entity_type": "Disease",
          "entity_name": "diarrhoea",
          "context": "included diarrhoea (9%)"
        },
        {
          "entity_type": "Disease",
          "entity_name": "headache",
          "context": "headache (6%)"
        },
        {
          "entity_type": "Disease",
          "entity_name": "nausea",
          "context": "and nausea (5%)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cilomilast",
          "context": "reported with cilomilast"
        },
        {
          "entity_type": "Disease",
          "entity_name": "abdominal pain",
          "context": "abdominal pain and vomiting"
        },
        {
          "entity_type": "Disease",
          "entity_name": "vomiting",
          "context": "and vomiting were also reported"
        },
        {
          "entity_type": "Disease",
          "entity_name": "cardiovascular liabilities",
          "context": "No cardiovascular liabilities were noted"
        }
      ]
    },
    {
      "chunk_id": "d9a4da17cb4dce753b32e19513edf9c5",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "PMNPQ",
          "context": "most potent emetic PDE4 inhibitor, PMNPQ"
        },
        {
          "entity_type": "Effect",
          "entity_name": "emetic",
          "context": "most potent emetic PDE4 inhibitor"
        },
        {
          "entity_type": "Effect",
          "entity_name": "emesis",
          "context": "ability to induce emesis"
        },
        {
          "entity_type": "Effect",
          "entity_name": "PDE4 inhibition",
          "context": "magnitude of PDE4 inhibition"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 inhibitors",
          "context": "between the various PDE4 inhibitors"
        }
      ]
    },
    {
      "chunk_id": "fa69ff6ba61e831f7394a0ebdd6ee4fc",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "tor agonists",
          "context": "tor agonists"
        },
        {
          "entity_type": "Compound",
          "entity_name": "bronchodilator drugs",
          "context": "combined with bronchodilator drugs"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 inhibitors",
          "context": "PDE4 inhibitors suppress"
        },
        {
          "entity_type": "Effect",
          "entity_name": "suppress",
          "context": "PDE4 inhibitors suppress and not exacerbate inflammation"
        },
        {
          "entity_type": "Effect",
          "entity_name": "exacerbate",
          "context": "suppress and not exacerbate inflammation"
        },
        {
          "entity_type": "Disease",
          "entity_name": "inflammation",
          "context": "exacerbate inflammation in the airways"
        }
      ]
    }
  ],
  "total_entities": 83,
  "extraction_date": "2026-02-01T08:14:16.323309+00:00"
}